BioCryst Pharmaceuticals
BCRX
#4619
Rank
$1.65 B
Marketcap
$8.01
Share price
-4.30%
Change (1 day)
45.90%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -$1.25

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.25. In 2022 the company made an earnings per share (EPS) of -$1.33 a decrease over its 2021 EPS that were of -$1.03.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.25-6.02%
2022-$1.3329.13%
2021-$1.03-4.63%
2020-$1.0810.2%
2019-$0.980%
2018-$0.9825.64%
2017-$0.784%
2016-$0.7527.12%
2015-$0.59-13.24%
2014-$0.6823.64%
2013-$0.55-30.38%
2012-$0.79-37.3%
2011-$1.2665.79%
2010-$0.76117.14%
2009-$0.35-46.15%
2008-$0.65-26.97%
2007-$0.89-40.67%
2006-$1.5048.51%
2005-$1.011%
2004-$1.0038.89%
2003-$0.72-25%
2002-$0.96231.03%
2001-$0.29-56.72%
2000-$0.6791.43%
1999-$0.352.94%
1998-$0.34-55.84%
1997-$0.7711.59%
1996-$0.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.09-267.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.83 526.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.59-52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.19 475.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.39-451.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.40 92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.50-380.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$12.08 866.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.77-38.40%๐Ÿ‡บ๐Ÿ‡ธ USA